NCT02961842

Brief Summary

The study will compare one technique of fluid administration (combined colloid preload and crystalloid colaod) with another one (crystalloid coload) during elective cesarean delivery performed under spinal anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 11, 2016

Completed
9 days until next milestone

Study Start

First participant enrolled

November 20, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2017

Completed
Last Updated

March 22, 2017

Status Verified

March 1, 2017

Enrollment Period

4 months

First QC Date

November 9, 2016

Last Update Submit

March 20, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total ephedrine dose

    intraoperative

Secondary Outcomes (8)

  • Incidence of hypotension

    intraoperative

  • Incidence of severe hypotension

    intraoperative

  • Time to the first ephedrine dose

    intraoperative

  • Heart rate

    intraoperative

  • Inferior vena cava largest and smallest diameters

    Baseline, at 1 and 5 minutes after intrathecal injection, delivery

  • +3 more secondary outcomes

Study Arms (2)

Combination

EXPERIMENTAL

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

Drug: 500 mL Colloid PreloadProcedure: Spinal AnesthesiaDrug: Intrathecal BupivacaineDrug: Intrathecal FentanylDrug: 500 mL Crystalloid ColoadProcedure: Cesarean DeliveryRadiation: Ultrasound Assessment of the Inferior Vena CavaDrug: Intravenous Ephedrine

Coload

ACTIVE COMPARATOR

1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

Procedure: Spinal AnesthesiaDrug: Intrathecal BupivacaineDrug: Intrathecal FentanylDrug: 1000 mL Crystalloid ColoadProcedure: Cesarean DeliveryRadiation: Ultrasound Assessment of the Inferior Vena CavaDrug: Intravenous Ephedrine

Interventions

6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (voluven®) 500 mL will be rapidly infused before spinal anesthesia

Combination

Performed at the L3-L4 or L4-L5 interspace using 27- or 25-gauge spinal needle

ColoadCombination

Bupivacaine 12.5 mg (2.5 mL 0.5%) will be administered in the subarachnoid space

ColoadCombination

Fentanyl 15 µg will be administered in the subarachnoid space

ColoadCombination

Ringer acetate 500 mL will be rapidly infused immediately after intrathecal injection

Combination

Ringer acetate 1000 mL will be rapidly infused immediately after intrathecal injection

Coload

Lower segment cesarean section using the Pfannenstiel incision

ColoadCombination

The inferior vena cava largest and smallest diameters will be measured proximal to the opening of the hepatic veins in the longitudinal axis with the M-mode using a 5-2 MHz curved array ultrasound probe placed longitudinally in the subxiphoid region

ColoadCombination

Intravenous ephedrine 3, 5, and 10 mg will be administered when Systolic blood pressure decreases below 90%, 80%, and 70% of baseline, respectively.

ColoadCombination

Eligibility Criteria

Age19 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists physical status II parturients
  • Full term, singleton pregnancy
  • Elective cesarean delivery under spinal anesthesia

You may not qualify if:

  • Age \<19 or \> 40 years
  • Height \<150 cm
  • Weight \<60 kg
  • Body mass index ≥40 kg/m2
  • Contraindications to spinal anesthesia (increased intracranial pressure, coagulopathy, or local skin infection)
  • Chronic or pregnancy-induced hypertension
  • Hemoglobin \<10 gm/dL.
  • Diabetes mellitus, cardiovascular, cerebrovascular, or renal disease
  • Polyhydramnios or known fetal abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesia, Mansoura University Hospitals

Al Mansurah, Dakahlia Governorate, 35511, Egypt

Location

Related Publications (1)

  • Tawfik MM, Tarbay AI, Elaidy AM, Awad KA, Ezz HM, Tolba MA. Combined Colloid Preload and Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery: A Randomized Controlled Trial. Anesth Analg. 2019 Feb;128(2):304-312. doi: 10.1213/ANE.0000000000003306.

MeSH Terms

Interventions

Anesthesia, SpinalCesarean Section

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaDelivery, ObstetricObstetric Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Mohamed M Tawfik, MD

    Mansoura University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Department of anesthesia and surgical intensive care, principal investigator

Study Record Dates

First Submitted

November 9, 2016

First Posted

November 11, 2016

Study Start

November 20, 2016

Primary Completion

March 9, 2017

Study Completion

March 9, 2017

Last Updated

March 22, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations